Slingshot members are tracking this event:

European Commission Expected to Make Final Decision in ~60 Days on Gilead's (GILD) Vemlidy in Adults with Chronic HBV Infection

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Additional Information

Additional Relevant Details Update on Nov 11 2016: European CHMP Adopts Positive Opinion for Gilead’s Vemlidy (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus Infection
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords European Comission, Chmp, Vemlidy, Chronic Hepatits B Virus Infection, Hbv, Tenofovir Alafenamide